Experienced CEOs from Korean pharmaceutical companies emphasized the need for three-way collaboration between early-stage biotechs, domestic pharmaceutical companies, and multinational drugmakers.Their comments came in the first keynote session at Bioplus-Interphex 2023 in Coex, Seoul, a global comp
In just six months this year, Samsung Biologics secured over 2 trillion won ($1.5 billion) in contract manufacturing organization (CMO) orders, the company said on Monday. The amount surpassed the annual orders of 2022 and it is the first time the figure reached 2 trillion won in the company’s histo
The National Cancer Center (NCC) and Korea University Research and Business Foundation said Thursday they licensed out a triple-negative breast cancer prognostic biomarker to CbsBiosciences, a Korean AI-backed biomarker developer.The triple-negative breast cancer prognostic biomarker discovers a bio
Samsung Bioepis and Celltrion Healthcare have launched biosimilars of the autoimmune disease treatment Humira (ingredient: adalimumab) in the U.S.Samsung Bioepis said last Saturday that it launched Hadlima, its Humira biosimilar, in the U.S. through its partner Organon.Hadlima is available in two fo
The emergence of biological agents in asthma pharmacotherapy is changing the treatment paradigm for severe asthma, previously characterized by bronchodilators and inhaled steroids (ICS).The advent of interleukin inhibitors has made it possible to establish phenotype-specific treatment strategies in
Researchers at the Institute of Basic Science (IBS) said on Friday that they developed a technology to predict the tendency to focus on negative thoughts and feelings and also the level of depression in people diagnosed with depression. Rumination occurs when a person becomes fixated on a thought or
Celltrion said it has filed a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for CT-P42, a biosimilar referencing Eylea (ingredient: aflibercept) for the treatment of ocular diseases.Based on the global phase 3 results of CT-P42, Celltrion has applied for marketing autho
The Korea Institute of Science and Technology (KIST) said on Thursday that it signed a business agreement with the Industrial Bank of Korea (IBK) and the German state of Saarland to support Korean start-up's entry into Europe. The agreement aims to support successful European entry and local commerc
The Korea Advanced Institute of Science and Technology (KAIST) said on Thursday that its adenovirus nasal Covid-19 vaccine confirmed strong mucosal immunity and that lung macrophages helped produce a sustained response in mouse models.Mucosal immunity protects the body from infection by recognizing
A team of researchers from the Institute for Basic Science (IBS) said they identified a new pathogenesis and treatment strategy for autistic patients with epilepsy lacking the Ank2 gene.Autism spectrum disorder (ASD) is characterized by deficits in social interaction and communication, and repetitiv
As Korea and Denmark are both actively pursuing initiatives to grow their respective biotech industries, the Danish embassy in Seoul hosted a webinar on Tuesday to elaborate on the upcoming Denmark-Korea Biotech Partnership Project.The project seeks to establish connections between Danish and Korean
SK plasma said it has received approval from the Singaporean Health Sciences Authority (HSA) for its blood products -- albumin and immunoglobulin -- and began full-scale production in June.SK plasma will be the exclusive supplier of blood products totaling $30 million over the next six years, starti
A team of researchers from CHA University and CHA Hospital has discovered biomarkers that are expected to help diagnose and treat patients with recurrent miscarriages.A team of researchers led by Professor Baek Kwang-hyun from CHA University Department of Biomedical Science identified that the genes
The brawl between Samsung Biologics and Lotte Biologics, in which the former has been accusing the latter of employee poaching and trade secret infringement, has entered a new stage as Samsung recently filed a preliminary injunction against Lotte Biologics.According to industry reports, Samsung Biol
SK pharmteco said that its French cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) subsidiary Yposkesi has completed its second plant, allowing the company to secure the largest CGT production capacity in Europe.According to the company, the second plant, locate
The Korean Society of Medical Oncology (KSMO) said it is preparing to organize its 16th annual meeting and 2023 International Conference (KSMO 2023) at the Grand Walker Hill Hotel in Seoul on Sept. 7-8.The conference is expected to draw a larger crowd than previous ones because the KSMO is holding c
Bioplus-Interphex (BIX) Korea 2023, a comprehensive biotechnology convention, hosted by Korea Biotechnology Industry Organization (KoreaBIO) and Reed Exhibitions Korea (RX), will bring together global experts in all areas of biotechnology from July 12 to 14 at COEX, Seoul.The first keynote session w
Korea Advanced Institute of Science & Technology (KAIST) said on Thursday that it developed a deep learning predictive model for detecting patients' risks of adverse effects to cancer immunotherapies.Cancer immunotherapy is a third-generation cancer treatment that activates a patient's immune system
Celltrion has decided on another share buyback worth 50 billion won ($38.7 million).Celltrion said Thursday it held a board meeting and decided to repurchase 314,466 shares of its common stock. It will be the company’s third share buyback, following February and March.Based on Wednesday's closing pr
Lotte Biologics said it has signed a four-way memorandum of understanding (MOU) with Lotte Holdings, Incheon Metropolitan City, and the Incheon Free Economic Zone Authority (IFEZA) to establish its biopharmaceutical production facility in Songdo.The signing ceremony, held at the IFEZ headquarters on